These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18979602)

  • 21. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population.
    Laupland KB; Kirkpatrick AW; Church DL; Ross T; Gregson DB
    J Hosp Infect; 2004 Oct; 58(2):137-45. PubMed ID: 15474185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of IA regimen followed by FLAG regimen in the treatment of acute myeloid leukaemia].
    Qian SX; Li JY; Hong M; Lu H; Wu HX; Qiu HX; Zhang SJ; Chen LJ; Xu W; Sheng RL
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):22-5. PubMed ID: 19563030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M; Thamlikitkul V
    J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols.
    Kato H; Fujita H; Akiyama N; Kimura SI; Hiramoto N; Hosono N; Takahashi T; Shigeno K; Minamiguchi H; Miyatake J; Handa H; Kanda Y; Yoshida M; Miyawaki S; Ohtake S; Naoe T; Kiyoi H; Matsumura I; Miyazaki Y;
    Support Care Cancer; 2018 Dec; 26(12):4187-4198. PubMed ID: 29860713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle.
    Ruutu T; Koivunen E; Nousiainen T; Pelliniemi TT; Almqvist A; Anttila P; Jantunen E; Koistinen P; Koponen A; Mikkola M; Oksanen K; Pulli T; Remes K; Sarkkinen R; Silvennoinen R; Timonen T; Vanhatalo S; Elonen E;
    Eur J Haematol; 2004 Jan; 72(1):38-44. PubMed ID: 14962261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia.
    Yi HS; Sym SJ; Park J; Cho EK; Shin DB; Lee JH
    Leuk Res; 2010 Jul; 34(7):e173-5. PubMed ID: 20074799
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
    López A; Soler JA; Juliá A; Novo A; Bueno J
    Med Clin (Barc); 1994 Jan; 102(3):81-5. PubMed ID: 8133717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols.
    Yilmaz S; Oren H; Demircioğlu F; Irken G
    Pediatr Hematol Oncol; 2008; 25(3):195-204. PubMed ID: 18432502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
    Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
    Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
    Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
    Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
    Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
    Cornely OA; Böhme A; Reichert D; Reuter S; Maschmeyer G; Maertens J; Buchheidt D; Paluszewska M; Arenz D; Bethe U; Effelsberg J; Lövenich H; Sieniawski M; Haas A; Einsele H; Eimermacher H; Martino R; Silling G; Hahn M; Wacker S; Ullmann AJ; Karthaus M;
    J Antimicrob Chemother; 2008 Apr; 61(4):939-46. PubMed ID: 18272515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bloodstream infections in hospitalized adults with sickle cell disease: a retrospective analysis.
    Chulamokha L; Scholand SJ; Riggio JM; Ballas SK; Horn D; DeSimone JA
    Am J Hematol; 2006 Oct; 81(10):723-8. PubMed ID: 16795063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphenotypic acute leukaemia: a case series.
    Aribi A; Bueso-Ramos C; Estey E; Estrov Z; O'Brien S; Giles F; Faderl S; Thomas D; Kebriaei P; Garcia-Manero G; Pierce S; Cortes J; Kantarjian H; Ravandi F
    Br J Haematol; 2007 Jul; 138(2):213-6. PubMed ID: 17593028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia.
    Almuneef MA; Memish ZA; Balkhy HH; Hijazi O; Cunningham G; Francis C
    J Hosp Infect; 2006 Feb; 62(2):207-13. PubMed ID: 16307822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloodstream infections in neutropenic patients with haematological malignancies.
    Carvalho AS; Lagana D; Catford J; Shaw D; Bak N
    Infect Dis Health; 2020 Feb; 25(1):22-29. PubMed ID: 31586572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
    Koistinen P; Räty R; Itälä M; Jantunen E; Koivunen E; Nousiainen T; Pelliniemi TT; Remes K; Ruutu T; Savolainen ER; Siitonen T; Silvennoinen R; Volin L; Elonen E;
    Eur J Haematol; 2007 Jun; 78(6):477-86. PubMed ID: 17391337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment.
    Shin HJ; Kim HJ; Sohn SK; Min YH; Won JH; Kim I; Yoon HJ; Lee JH; Jo DY; Joo YD; Jung CW; Lee KH; ; Chung JS; Ahn JS; Kim SJ; Lee JH; Choi SJ; Lee JH; Bae SH; Hong DS; Zang DY; Kim SH; Lee JL; Bang SM
    Jpn J Clin Oncol; 2010 Jun; 40(6):556-66. PubMed ID: 20185460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.